Adapttech is a technology company.
Adapttech is a technology company.
Adapttech has raised $3.0M across 1 funding round.
Adapttech has raised $3.0M in total across 1 funding round.
Adapttech is a biomedical innovation company founded in 2015 that develops smart, wearable technologies for the orthotics and prosthetics (O&P) industry, focusing on remote patient monitoring for lower-limb prosthetic users.[1][2][6] Its key products, like the INSIGHT Range, provide data-driven solutions to O&P clinics and insurance companies, aiding clinical decision-making and improving patient outcomes for those with physical limitations.[1][2] The company serves healthcare providers, prosthetists, rehabilitation centers, and patients, addressing challenges in prosthetic care such as monitoring and optimization; it has raised $7.33M total, with its latest Series C round of ~$2.9M in 2022 from investors including Mercia Asset Management, ACF Investors, Wren Capital, Wealth Club, and Bionova Capital, signaling steady growth before its acquisition.[1][2]
In April (year not specified in sources, but post-2022 funding), Amparo, a direct-fit prosthetic socket manufacturer, acquired Adapttech to integrate its smart tech with socket solutions, creating a holistic prosthetic care approach for better comfort and function; post-acquisition, Adapttech's former CEO Frederico Carpinteiro became Amparo's CEO.[4]
Adapttech was founded in 2015 in Birmingham, England, at the Institute of Translational Medicine, by Dr. Edward Haeggström, a Finnish physicist with a Ph.D. from the University of Helsinki and an MBA in innovation management.[1] Haeggström, born in 1969, brought commercial experience from roles at Dr. Reddy's (Head of Asia Pacific Sales), Prosonix Ltd (global business development), and prior sales positions, driving the company's focus on biomedical tech for O&P.[1] The idea emerged from a need for remote monitoring in prosthetics, leading to early traction via products that empower clinics with patient data; pivotal funding included a £2.25M (~$2.9M) round in April 2022, supporting commercial expansion amid market presence.[1][2][8] This culminated in its acquisition by Amparo on April 2 (year unspecified), merging teams and leadership for scaled impact.[4]
Adapttech rides the wave of digital health and medtech innovation in O&P, where aging populations and rising limb loss rates (from diabetes, trauma) drive demand for smart, data-driven prosthetics amid a market favoring remote monitoring post-COVID.[1][2][8] Timing aligns with regulatory pushes for outcome-based care and insurer adoption of tech for cost savings; market forces like wearable sensor advancements and AI analytics favor its solutions over static prosthetics.[1][4] By merging with Amparo, it influences the ecosystem toward integrated "prosthetic ecosystems," boosting UK/EU medtech hubs like Birmingham and accelerating adoption in rehab, potentially setting standards for holistic care.[1][2][4]
Post-acquisition, Adapttech's tech will likely fuel Amparo's growth under new CEO Frederico Carpinteiro, expanding the INSIGHT Range globally and tackling execution risks in sales penetration.[2][4][8] Trends like AI-enhanced prosthetics, regulatory streamlining for wearables, and insurer data mandates will shape its path, evolving influence from niche innovator to ecosystem leader in personalized O&P care. As medtech consolidates, this merger positions it to redefine mobility for millions, building on its biomedical roots to deliver scalable, life-changing tech.[1][4]
Adapttech has raised $3.0M in total across 1 funding round.
Adapttech's investors include ACF Investors.
Adapttech has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Series A in April 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2022 | $3.0M Series A | ACF Investors |